Regulus Therapeutics
RGLS
#8590
Rank
โ‚ฌ0.11 B
Marketcap
1,81ย โ‚ฌ
Share price
6.19%
Change (1 day)
-13.33%
Change (1 year)

Revenue for Regulus Therapeutics (RGLS)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Regulus Therapeutics from 2012 to 2024

Annual revenue

Year Revenue Change
2024 N/A
2023 N/A
2022 N/A
2021 N/A-100%
2020 โ‚ฌ8.13 M33.39%
2019 โ‚ฌ6.09 M9590.19%
2018 โ‚ฌ0.06 M4.88%
2017 โ‚ฌ0.06 M-94.71%
2016 โ‚ฌ1.13 M-94.02%
2015 โ‚ฌ18.98 M201.09%
2014 โ‚ฌ6.3 M-55.5%
2013 โ‚ฌ14.17 M47.59%
2012 โ‚ฌ9.6 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ35.25 BN/A๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ42.08 BN/A๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ8.49 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ47.44 BN/A๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ1.97 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ50.71 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ42.38 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.16 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA